Compass Therapeutics, Inc. (CMPX) earnings

CMPX earnings moved a median of 0.00% by the close. Quarterly and annual CMPX reports and results, each read against the price at its own news timestamp. Back to the CMPX overview →

14 measured CMPX earnings events.

Where these CMPX earnings landedvs 14 measured CMPX earnings reactions
CMPX earningsMiddle 50% · -6.29% to +2.29%Zero: 0.00%Median: 0.00%Median 0.00%-8.00%0+8.00%
Middle 50% of CMPX earnings reactions-6.29% to +2.29%
Median reaction (to close)0.00%
Measured reactions14
Point-in-time · zero look-ahead

Half of the 14 CMPX earnings events with a measured close landed between -6.29% and +2.29%; 43% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Compass Therapeutics, For: Jun 30SEC filing · Form 10-Q-0.52%+3.11%
Form 10-Q Compass Therapeutics, For: Mar 31SEC filing · Form 10-Q-2.83%+0.52%
Form 10-K Compass Therapeutics, For: Dec 31SEC filing · Form 10-K+1.08%+0.00%
Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate UpdatePress release-0.26%+0.00%
Form 10-Q Compass Therapeutics, For: Sep 30SEC filing · Form 10-Q-0.26%+0.00%
Form 10-Q Compass Therapeutics, For: Jun 30SEC filing · Form 10-Q+3.68%+22.79%
Form 10-Q Compass Therapeutics, For: Mar 31SEC filing · Form 10-Q+0.00%+5.95%
Form 10-K Compass Therapeutics, For: Dec 31SEC filing · Form 10-K+0.00%-2.67%
Form 10-Q Compass Therapeutics, For: Sep 30SEC filing · Form 10-Q-2.84%-7.49%
Form 10-Q Compass Therapeutics, For: Jun 30SEC filing · Form 10-Q+4.91%+0.89%
Form 10-Q Compass Therapeutics, For: Mar 31SEC filing · Form 10-Q-2.92%-8.77%
Form 10-K Compass Therapeutics, For: Dec 31SEC filing · Form 10-K+0.69%+2.75%
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdatePress release+0.57%-8.52%
Form 10-Q Compass Therapeutics, For: Sep 30SEC filing · Form 10-Q+0.57%-8.52%
That’s how CMPX usually reacts to earnings — get an email when it moves on news →
Keep exploring

More CMPX: analyst actions → · SEC filings → · CMPX overview →